Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. (HARP) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 268 transactions totaling $616.9M, demonstrating a bullish sentiment with $487.0M in net insider flow. The most recent transaction on Mar 11, 2024 involved a purchase of 21,397,205 shares valued at $492.1M.
HARP Insider Activity Summary
Who Is Buying HARP Stock?
No significant insider buying has been recorded for HARP in the recent period.
Who Is Selling HARP Stock?
No significant insider selling has been recorded for HARP in the recent period.
Is Harpoon Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for HARP is bullish with an Insider Alignment Score of 89/100 and a net flow of $487.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
HARP Frequently Asked Questions
Understanding HARP Insider Activity
Insider trading at Harpoon Therapeutics, Inc. (HARP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading HARP stock, having executed 268 transactions in the past 90 days. The most active insider is &. Co., Inc. Merck (Executive), who has made 1 transactions totaling $492.1M.
Related Tools
Track Harpoon Therapeutics, Inc. Insider Activity
Get notified when executives and directors at HARP file new Form 4 transactions